NAVIGATOR data show half of patients with severe, uncontrolled asthma improved with tezepelumab therapy
A greater proportion of patients with severe, uncontrolled asthma had more significant clinical responses to tezepelumab than placebo, according to research published at the ATS 2022 international conference. The study showed ...
May 17, 2022
0
11